WVCTSI has announced the formation of an intensive writing group designed for investigators interested in developing National Institutes of Health (NIH) R03 applications. This five-week intensive writing group will begin in May and offers participants the opportunity to receive structured guidance and feedback on their application for the June 2018 submission deadline.
R03 research grants support a variety of projects including pilot or feasibility studies, collection of preliminary data, secondary analysis of existing data, small self-contained research projects, development of new research technology, and more.
Interested participants should visit the program webpage for additional information and complete application instructions. Applications must be submitted by 5 p.m. EST on Monday, April 16. Please email Joan Lakoski, Ph.D., WVCTSI director of proposal development, for more information
Mike Ridinger joins WVU Cancer Institute as Assistant Director of Finance and Administration and Administrator of Hematology/Oncology
The WVU Cancer Institute welcomes Mike Ridinger, R.N., M.B.A., as assistant director of finance and administration and the administrator of Hematology/Oncology.
Rich Goldberg, M.D., director of the WVU Cancer Institute and Laurence S. and Jean J. DeLynn chair of Oncology, will step down from those positions and transition toward retirement once an interim is named or at the end of the calendar year.